SEARCH

SEARCH BY CITATION

References

  • 1
    Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. JAllergyClin Immunol 2004;6(Suppl):155212.
  • 2
    Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;3(Suppl):S1S32.
  • 3
    Banerji A, Piccirillo JF, Thawley SE, Levitt RG, Schechtman KB, Kramper MA et al. Chronic rhinosinusitis patients with polyps or polypoid mucosa have a greater burden of illness. Am J Rhinol 2007;21:1926.
  • 4
    Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006;61:12801289.
  • 5
    Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G et al. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis – a GALEN study. Allergy 2009;64:520533.
  • 6
    Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009;124:253259, 259 e251–252.
  • 7
    Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005;22:131142.
  • 8
    Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006;65(Suppl. 3):iii61iii64.
  • 9
    Dahl CA, Schall RP, He HL, Cairns JS. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992;148:597603.
  • 10
    Bai X, Kim SH, Azam T, McGibney MT, Huang H, Dinarello CA et al. IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J Immunol 2010;184:38303840.
  • 11
    Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E et al. Identification of the most active interleukin-32 isoform. Immunology 2009;126:535542.
  • 12
    Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA. IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci U S A 2009;106:38833888.
  • 13
    Meyer N, Zimmermann M, Burgler S, Bassin C, Woehrl S, Moritz K et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 2010;125:858865.
  • 14
    Nishida A, Andoh A, Shioya M, Kim-Mitsuyama S, Takayanagi A, Fujiyama Y. Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2008;294:G831G838.
  • 15
    Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S et al. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007;149:480486.
  • 16
    Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A 2005;102:1630916314.
  • 17
    Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED et al. Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta. Cytokine 2010;49:171176.
  • 18
    Goda C, Kanaji T, Kanaji S, Tanaka G, Arima K, Ohno S et al. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 2006;18:233240.
  • 19
    Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D et al. Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med 2006;3:e277.
  • 20
    Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH et al. Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 2008;181:557565.
  • 21
    Li W, Sun W, Liu L, Yang F, Li Y, Chen Y et al. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol 2010;185:50565065.
  • 22
    Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 2006;103:32983303.
  • 23
    Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:894901.
  • 24
    Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005;16:289292.
  • 25
    Pearlman AN, Conley DB. Review of current guidelines related to the diagnosis and treatment of rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2008;16:226230.
  • 26
    Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2008;121:13851392.
  • 27
    Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007;179:10801087.
  • 28
    Kato A, Truong-Tran AQ, Scott AL, Matsumoto K, Schleimer RP. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol 2006;177:71647172.
  • 29
    Chustz RT, Nagarkar DR, Poposki JA, Favoreto S Jr, Avila PC, Schleimer RP et al. Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2011;45:145153.
  • 30
    Poposki JA, Uzzaman A, Nagarkar DR, Chustz RT, Peters AT, Suh LA et al. Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2011;128:7381.e74.
  • 31
    Tieu DD, Peters AT, Carter RT, Suh L, Conley DB, Chandra R et al. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis. J Allergy Clin Immunol 2010;125:667675.
  • 32
    Claeys S, De Belder T, Holtappels G, Gevaert P, Verhasselt B, Van Cauwenberge P et al. Macrophage mannose receptor in chronic sinus disease. Allergy 2004;59:606612.
  • 33
    Patadia M, Dixon J, Conley D, Chandra R, Peters A, Suh LA et al. Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis. Am J Rhinol Allergy 2010;24:1116.